Laboratory of Biomaterials, Key Laboratory on Assisted Circulation, Ministry of Health, Cardiovascular Division, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Institute of Stomatological Research, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Int J Nanomedicine. 2022 Nov 25;17:5679-5696. doi: 10.2147/IJN.S383862. eCollection 2022.
iRGD is usually used as a motif to modify siRNA-nanodelivery vectors to improve tumor-targeting and penetration. However, most of the modifications are realized by covalent conjugation, which normally requires complex preparation processes possibly with low conjugation efficiency and yield, and might lower its bioactivity. To avoid this, here, we presented an alternative physical method to decorate iRGD on nanopolymersomes via facile self-assembly in water.
was chosen as a siRNA model, and lipopolysaccharide-amine nanopolymersomes (NPs), an efficient cytosolic delivery vector developed by our group, was used as an original vector. By successively incubating with NPs, followed by adding iRGD, a -loaded NPs functionalized with iRGD (siRNA/iRGD-NPs) was obtained. The properties of iRGD-NPs or siRNA/iRGD-NPs were evaluated in vitro and in vivo.
iRGD is efficiently introduced onto NPs with different amounts, which can be precisely controlled by the feeding ratio. The introduced iRGD keeps tumor-targeting and -penetrating bioactivity, which endows iRGD-NPs with ~100% of tumor-cell uptake and excellent tumor spheroid-penetration, and thus iRGD-NPs can efficiently deliver to significantly inhibit angiogenesis in zebrafish and tumor growth in nude mice bearing breast cancer without obvious toxicity.
This study provides a facile physical method to decorate nanodelivery vectors with iRGD for effective targeted siRNA anti-tumor therapy.
iRGD 通常被用作修饰 siRNA-纳米递药载体以提高肿瘤靶向性和穿透性的基序。然而,大多数修饰都是通过共价键合来实现的,这通常需要复杂的制备过程,可能具有低的结合效率和产率,并且可能降低其生物活性。为了避免这种情况,我们在此提出了一种替代的物理方法,通过在水中的简单自组装将 iRGD 修饰到纳米聚合物泡囊上。
选择作为 siRNA 模型,我们课题组开发的高效细胞内递药载体脂多糖-胺纳米聚合物泡囊(NPs)被用作原始载体。通过依次孵育与 NPs,然后加入 iRGD,成功制备了负载 iRGD 的 NPs(siRNA/iRGD-NPs)。通过体外和体内评价 iRGD-NPs 或 siRNA/iRGD-NPs 的性质。
iRGD 以不同的量被有效地引入到 NPs 中,其可以通过进料比来精确控制。引入的 iRGD 保持肿瘤靶向和穿透的生物活性,赋予 iRGD-NPs 对肿瘤细胞的摄取率接近 100%和出色的肿瘤球体穿透能力,从而使 iRGD-NPs 能够有效地将 递送到斑马鱼中,显著抑制血管生成,并在荷乳腺癌裸鼠中抑制肿瘤生长而无明显毒性。
本研究提供了一种简便的物理方法,用于用 iRGD 修饰纳米递药载体,以实现有效的靶向 siRNA 抗肿瘤治疗。